Matches in SemOpenAlex for { <https://semopenalex.org/work/W2157841216> ?p ?o ?g. }
- W2157841216 endingPage "661" @default.
- W2157841216 startingPage "651" @default.
- W2157841216 abstract "OBJECTIVE; To analyze the access and utilization profile of biological medications for psoriasis provided by the judicial system in Brazil.This is a cross-sectional study. We interviewed a total of 203 patients with psoriasis who were on biological medications obtained by the judicial system of the State of Sao Paulo, from 2004 to 2010. Sociodemographics, medical, and political-administrative characteristics were complemented with data obtained from dispensation orders that included biological medications to treat psoriasis and the legal actions involved. The data was analyzed using an electronic data base and shown as simple variable frequencies. The prescriptions contained in the lawsuits were analyzed according to legal provisions.A total of 190 lawsuits requesting several biological drugs (adalimumab, efalizumab, etanercept, and infliximab) were analyzed. Patients obtained these medications as a result of injunctions (59.5%) or without having ever demanded biological medication from any health institution (86.2%), i.e., public or private health services. They used the prerogative of free legal aid (72.6%), even though they were represented by private lawyers (91.1%) and treated in private facilities (69.5%). Most of the patients used a biological medication for more than 13 months (66.0%), and some patients were undergoing treatment with this medication when interviewed (44.9%). Approximately one third of the patients discontinued treatment due to worsening of their illness (26.6%), adverse drug reactions (20.5%), lack of efficacy, or because the doctor discontinued this medication (13.8%). None of the analyzed medical prescriptions matched the legal prescribing requirements. Clinical monitoring results showed that 70.3% of the patients had not undergone laboratory examinations (blood work, liver and kidney function tests) for treatment control purposes.The plaintiffs resorted to legal action to get access to biological medications because they were either unaware or had difficulty in accessing them through institutional public health system procedures. Access by means of legal action facilitated long-term use of this type of medication through irregular prescriptions and led to a high rate of adverse drug reactions as well as inappropriate clinical monitoring." @default.
- W2157841216 created "2016-06-24" @default.
- W2157841216 creator A5026942372 @default.
- W2157841216 creator A5030656424 @default.
- W2157841216 creator A5050794064 @default.
- W2157841216 creator A5061268506 @default.
- W2157841216 creator A5072118875 @default.
- W2157841216 creator A5075986489 @default.
- W2157841216 date "2014-08-01" @default.
- W2157841216 modified "2023-10-18" @default.
- W2157841216 title "Biological drugs for the treatment of psoriasis in a public health system" @default.
- W2157841216 cites W1607447489 @default.
- W2157841216 cites W1701993624 @default.
- W2157841216 cites W1788977473 @default.
- W2157841216 cites W1991589992 @default.
- W2157841216 cites W2017200913 @default.
- W2157841216 cites W2019607185 @default.
- W2157841216 cites W2043900942 @default.
- W2157841216 cites W2062822873 @default.
- W2157841216 cites W2063118071 @default.
- W2157841216 cites W2110441300 @default.
- W2157841216 cites W2116640162 @default.
- W2157841216 cites W2137231813 @default.
- W2157841216 cites W2138709341 @default.
- W2157841216 cites W2138977208 @default.
- W2157841216 cites W2142489516 @default.
- W2157841216 doi "https://doi.org/10.1590/s0034-8910.2014048005109" @default.
- W2157841216 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4181104" @default.
- W2157841216 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25210824" @default.
- W2157841216 hasPublicationYear "2014" @default.
- W2157841216 type Work @default.
- W2157841216 sameAs 2157841216 @default.
- W2157841216 citedByCount "7" @default.
- W2157841216 countsByYear W21578412162015 @default.
- W2157841216 countsByYear W21578412162017 @default.
- W2157841216 countsByYear W21578412162019 @default.
- W2157841216 countsByYear W21578412162020 @default.
- W2157841216 countsByYear W21578412162021 @default.
- W2157841216 countsByYear W21578412162023 @default.
- W2157841216 crossrefType "journal-article" @default.
- W2157841216 hasAuthorship W2157841216A5026942372 @default.
- W2157841216 hasAuthorship W2157841216A5030656424 @default.
- W2157841216 hasAuthorship W2157841216A5050794064 @default.
- W2157841216 hasAuthorship W2157841216A5061268506 @default.
- W2157841216 hasAuthorship W2157841216A5072118875 @default.
- W2157841216 hasAuthorship W2157841216A5075986489 @default.
- W2157841216 hasBestOaLocation W21578412161 @default.
- W2157841216 hasConcept C126322002 @default.
- W2157841216 hasConcept C138816342 @default.
- W2157841216 hasConcept C159110408 @default.
- W2157841216 hasConcept C16005928 @default.
- W2157841216 hasConcept C197934379 @default.
- W2157841216 hasConcept C2426938 @default.
- W2157841216 hasConcept C2777138892 @default.
- W2157841216 hasConcept C2777226972 @default.
- W2157841216 hasConcept C2777575956 @default.
- W2157841216 hasConcept C2779134260 @default.
- W2157841216 hasConcept C2780132546 @default.
- W2157841216 hasConcept C2780564577 @default.
- W2157841216 hasConcept C512399662 @default.
- W2157841216 hasConcept C71924100 @default.
- W2157841216 hasConcept C98274493 @default.
- W2157841216 hasConceptScore W2157841216C126322002 @default.
- W2157841216 hasConceptScore W2157841216C138816342 @default.
- W2157841216 hasConceptScore W2157841216C159110408 @default.
- W2157841216 hasConceptScore W2157841216C16005928 @default.
- W2157841216 hasConceptScore W2157841216C197934379 @default.
- W2157841216 hasConceptScore W2157841216C2426938 @default.
- W2157841216 hasConceptScore W2157841216C2777138892 @default.
- W2157841216 hasConceptScore W2157841216C2777226972 @default.
- W2157841216 hasConceptScore W2157841216C2777575956 @default.
- W2157841216 hasConceptScore W2157841216C2779134260 @default.
- W2157841216 hasConceptScore W2157841216C2780132546 @default.
- W2157841216 hasConceptScore W2157841216C2780564577 @default.
- W2157841216 hasConceptScore W2157841216C512399662 @default.
- W2157841216 hasConceptScore W2157841216C71924100 @default.
- W2157841216 hasConceptScore W2157841216C98274493 @default.
- W2157841216 hasIssue "4" @default.
- W2157841216 hasLocation W21578412161 @default.
- W2157841216 hasLocation W21578412162 @default.
- W2157841216 hasLocation W21578412163 @default.
- W2157841216 hasLocation W21578412164 @default.
- W2157841216 hasOpenAccess W2157841216 @default.
- W2157841216 hasPrimaryLocation W21578412161 @default.
- W2157841216 hasRelatedWork W129828253 @default.
- W2157841216 hasRelatedWork W2014044177 @default.
- W2157841216 hasRelatedWork W2023723287 @default.
- W2157841216 hasRelatedWork W2147572249 @default.
- W2157841216 hasRelatedWork W2280945256 @default.
- W2157841216 hasRelatedWork W2287117830 @default.
- W2157841216 hasRelatedWork W2737526559 @default.
- W2157841216 hasRelatedWork W2936224517 @default.
- W2157841216 hasRelatedWork W2978616557 @default.
- W2157841216 hasRelatedWork W4307091443 @default.
- W2157841216 hasVolume "48" @default.
- W2157841216 isParatext "false" @default.
- W2157841216 isRetracted "false" @default.
- W2157841216 magId "2157841216" @default.